Motivity secured a $27 million investment from Five Elms Capital to enhance its clinical SaaS solutions for ABA providers, aiming to accelerate product innovation and expand global reach.

Information on the Target

Motivity is a prominent provider of clinical software-as-a-service (SaaS) solutions catering to Applied Behavior Analysis (ABA) practitioners who work with children diagnosed with autism. Established in 2012, the company's core mission revolves around equipping ABA clinicians with advanced technological tools that enhance clinical effectiveness and improve patient outcomes. To date, Motivity has successfully secured $11 million in Small Business Innovative Research (SBIR) grants, which have facilitated the development of innovative solutions, such as artificial intelligence-driven workflows and analytics designed for informed clinical decision-making.

Currently, Motivity services over 550 organizations across seven countries, making significant strides in the delivery of high-quality, data-driven care to children with autism and their families. This expansive growth underscores the demand for sophisticated software solutions within the healthcare landscape.

Industry Overview in the Target’s Specific Country

The behavioral health technology industry in the United States has seen remarkable growth in recent years, driven by an increased awareness and diagnosis of autism spectrum disorder (ASD). As a result, there is a heightened need for